Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Chinese Adults With TSC-Associated Renal Angiomyolipoma
NCT03525834Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in renal angiomyolipoma (AML), sponsored by Novartis. Started Nov 2018; status: completed.
02
Drugs
everolimus
03
Conditions
renal angiomyolipoma (AML)
Beyond the preview
Go deeper on NCT03525834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03525834.